Clinical Trial Update: Safety and Efficacy of TareSphere in Patients With Unresectable Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and preliminary efficacy of TareSphere in patients with unresectable hepatocellular carcinoma. The study has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• TareSphere

Snippet

Sponsor: Chengdu New Radiomedicine Technology Co. LTD. | Conditions: Unresectable Hepatocellular Carcinoma | Phase 1 | Status: COMPLETED